Resources

Access expert content and insights, including whitepapers, case studies, presentations, and other valuable resources here.

GMP Manufacturing of Oncolytic Viruses: Critical Steps an…

The oncolytic virus (OV) sector needs to overcome several challenges to bring transformative cancer therapeutics to the clinic.   Not only …

What is the Secret to Oncolytic Virus Development?

There are few contract development and manufacturing organizations (CDMOs) capable of working with biopharmaceutical companies to develop adva…

Virus Particle Analysis by MADLS Technology

Over the past two decades, we have seen continued advancement of virus characterization and quantification technologies come to market due to …

Time to Outsource Viral Vector Development

A fast-growing sector The outsourcing of process development, manufacturing, and analytical testing in the viral product market has grown sig…

The Advantage of Engaging Your CDMO Early

One of the key things that I have learned from my many years in the biopharma market is that it is not only important to work with a trusted c…

Top Tips in Selecting your Viral Vector Partner

From cutting-edge therapies for deadly cancers, to developing effective vaccines, the viral vector space is an exciting place to be. However, …